Wenqing Zhang

发表

Approaches to use the WHO respiratory syncytial virus surveillance platform to estimate disease burden

Peter G. Smith, R. Pebody, H. Nair, 2019, Influenza and other respiratory viruses.

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE

M. Peiris, M. V. Van Kerkhove, A. Heath, 2015, Clinical and Vaccine Immunology.

International Laboratory Comparison of Influenza Microneutralization Assays for A ( H 1 N 1 ) pdm 09 , A ( H 3 N 2 ) , and A ( H 5 N 1 ) Influenza Viruses by CONSISE

M. Peiris, A. Heath, K. Laurie, 2015 .

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.

Keiji Fukuda, Richard Webby, Takato Odagiri, 2010, Vaccine.

Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection

K. Vandemaele, A. Mounts, A. Yahaya, 2017, Bulletin of the World Health Organization.

An international laboratory comparison of influenza microneutralisation assay 2

M. Peiris, A. Heath, K. Laurie, 2015 .

Speaker Manuscripts

J. Tam, C. Penn, S. Briand, 2011, Influenza and other respiratory viruses.

Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection: guide for field operations

F. Hayden, M. Perdue, J. Lubroth, 2006 .

Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses

R. Webby, J. Peiris, C. Davis, 2020, Reviews in medical virology.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020

R. Webby, Dayan Wang, L. Gubareva, 2022, Antiviral research.

Evaluation of using ICD‐10 code data for respiratory syncytial virus surveillance

W. Haas, S. Buda, S. Hirve, 2019, Influenza and other respiratory viruses.

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016‐17

I. Barr, M. Zambon, J. Ellis, 2020, Influenza and other respiratory viruses.

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Eneida L. Hatcher, S. Lindstrom, I. Barr, 2021, Emerging infectious diseases.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017

Dayan Wang, S. Maurer-Stroh, L. Gubareva, 2018, Antiviral research.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Uzma Bashir, Mahmudur Rahman, N. Cox, 2015, Vaccine.

United States Centers for Disease Control and Prevention support for influenza surveillance, 2013–2021

Xiyan Xu, J. Bresee, K. Vandemaele, 2022, Bulletin of the World Health Organization.

Human respiratory syncytial virus and influenza seasonality patterns—Early findings from the WHO global respiratory syncytial virus surveillance

I. Barr, C. Bancej, J. Ellis, 2020, Influenza and other respiratory viruses.

Leveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance—opportunities and challenges

Peter G. Smith, H. Nair, H. Campbell, 2019, Influenza and other respiratory viruses.

The Global Influenza Surveillance and Response System—65 years of building trust and sharing and a role model for global health security

J. Wood, Wenqing Zhang, 2018, Influenza and other respiratory viruses.

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

R. Webby, Dayan Wang, N. Cox, 2012, Vaccine.

Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected

N. Cox, T. Ziegler, A. Moen, 2022, The Lancet.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016

Dayan Wang, L. Gubareva, S. Leang, 2017, Antiviral research.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015

Ha T. Nguyen, Dayan Wang, S. Maurer-Stroh, 2014, Antiviral research.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014

Dayan Wang, L. Gubareva, S. Leang, 2015, Antiviral research.

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.

Dayan Wang, L. Gubareva, A. Hurt, 2020, Antiviral research.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

Sarah Cobey, Neil Ferguson, Maria Zambon, 2013, Influenza and other respiratory viruses.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013

Dayan Wang, L. Gubareva, A. Hurt, 2014, Antiviral research.

Influenza Seasonality in the Tropics and Subtropics – When to Vaccinate?

K. Vandemaele, J. Paget, N. Bhat, 2016, PloS one.

Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics – a systematic literature review

K. Vandemaele, J. Paget, J. Fitzner, 2016, Influenza and other respiratory viruses.

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

R. Webby, Dayan Wang, N. Cox, 2014, Vaccine.

Clinical characteristics, predictors, and performance of case definition—Interim results from the WHO global respiratory syncytial virus surveillance pilot

N. Crawford, R. Palekar, S. Hirve, 2019, Influenza and other respiratory viruses.

Seasonal vaccines – Critical path to pandemic influenza response

M. Kieny, S. Hirve, Wenqing Zhang, 2017, Vaccine.

Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011.

M. Peiris, N. Cox, Maria Y. Giovanni, 2013, Vaccine.

Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

N. Ferguson, A. Monto, N. Cox, 2011, Influenza and other respiratory viruses.

Can we beat influenza?

R. Webster, Robert G. Webster, Wenqing Zhang, 2017, Science.

Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes

W. Haas, S. Buda, S. Hirve, 2020, Influenza and other respiratory viruses.

Leveraging Global Influenza Surveillance and Response System for the COVID-19 Pandemic Response and Beyond

D. Pereyaslov, M. Medina, S. Hirve, 2021, China CDC weekly.